$0.00 donated
0 Donors


The mission of iBIO Institute’s PROPEL Center is to increase the number and success rates of life sciences start-ups in Illinois.

PROPEL is a group of programs aimed at increasing the number and success rates of life sciences startups in Illinois.Industry initially led the development of PROPEL through generous support from Abbott/AbbVie, Astellas Pharma US, Inc., Baxter International Inc. and Takeda Pharmaceuticals North America.

Today, PROPEL has strong support from the broad life sciences community encompassing the three pillars of financial support: corporate/industry; private foundations; and public/government. In the last several years, funding sources include: iBIO, corporate partners (listed above), grants from the Searle Funds of The Chicago Community Trust, the City of Chicago and Illinois DCEO.